Haiming Wu

Haiming Wu

Company: Sanofi

Job title: Head of New Device Technology Research & Innovation

Seminars:

Panel Discussion: Matching Mechanism to Disease – Optimizing CNS Delivery Strategies Across Indications to Enhance Treatment Efficacy & Safety 4:30 pm

Where systemic vs. direct (e.g., IT, ICV, convection-enhanced) routes are used How targeting location, BBB access, and regional specificity guide decision-making The impact of disease stage and progression on delivery strategyRead more

day: Day One - Afternoon

Round-table Discussion: Straight to the Targett: Exploring the Role of Direct CNS Access in Modern Therapeutics to Solidify Local Administration in the Clinic 2:00 pm

Highly interactive breakout discussions designed to crowdsource solutions, share cross-functional insights, and explore the practical barriers to clinical adoption. What safety, procedural, or monitoring strategies are most critical to de-risk intra- CSF and other direct CNS delivery methods in clinical trials? How can integration between therapeutic formulation and delivery systems be optimized to accelerate approval…Read more

day: Day One - Afternoon - Track B

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.